Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation

European Respiratory Journal

Volumn 22, Issue 3, 2003, Pages 560-562

  Abramowicz, M J ^a,b   Van Haecke, P ^c   Demedts, M ^d   Delcroix, M ^d  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c St Rembertziekenhuis   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Appetite suppressant drugs; Bone morphogenetic protein receptor type II; Primary pulmonary hypertension; Serotonin

Indexed keywords

AMFEPRAMONE; AMINOREX; AMPHETAMINE; ANOREXIGENIC AGENT; BONE MORPHOGENETIC PROTEIN RECEPTOR; BOSENTAN; DEXFENFLURAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENFLURAMINE; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; DEATH; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HEART RIGHT VENTRICLE FAILURE; HEREDITARY HYPERTENSION; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ARTERY PRESSURE; MOLECULAR GENETICS; PENETRANCE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; APPETITE DEPRESSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DIETHYLPROPION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; METHYLPHENIDATE; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE;

EID: 0042881023     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00095303     Document Type: Article

References (15)

1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998; 352: 719-725.
2. Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67: 737-744.
3. The International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 2000; 26: 81-84.
4. Rich S. Primary pulmonary hypertension: executive summary from the world symposium-primary pulmonary hypertension (1998). World Health Organization www.who.int/ncd/cvd/pph.html. Date updated: July 3 2001. Date last accessed: March 6 2002.
5. Thomson JR, Machado RD, Panciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding for BMPR-II, a receptor of the TGF-beta family. J Med Gen 2000; 37: 741-745.
6. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335: 609-616.
7. Delcroix M, Kurz X, Walckiers D, Demedts M, Naeije R. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Eur Respir J 1998; 12: 271-276.
8. Gurtner HP. Aminorex and pulmonary hypertension. A review. Cor Vasa 1985; 27: 160-171.
9. Humbert M, Deng Z, Simonneau G, et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 2002; 20: 518-523.
10. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
11. Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001; 68: 92-102.
12. Rothman RB, Baumann MH. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 2002; 71: 825-836.
13. Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 2000; 97: 2591-2596.
14. Massagué J, Blain SW, Lo R. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
15. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: 2-11.